(Q48158712)

English

The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

chemoradiotherapy

0 references

0 references

hypermethylation

1 reference

based on heuristic

inferred from title

author name string

M Rapp

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

M Goeppert

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

J Felsberg

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

H J Steiger

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

M Sabel

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

publication date

18 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

British Journal of Neurosurgery

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

27

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

430-435

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2013.767317

21 January 2018

Identifiers

10.3109/02688697.2013.767317

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/23418781

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48158712&oldid=1423585886"